Mary E.D. Flowers

Active 1990–2024

167
Papers
41,390
Citations
104
h-index
167
i10-index

Citations

Citations per year for Mary E.D. Flowers1976: 1 citations1991: 1 citations1992: 3 citations1993: 2 citations1994: 1 citations1995: 3 citations1996: 5 citations1997: 8 citations1998: 18 citations1999: 27 citations2000: 46 citations2001: 87 citations2002: 163 citations2003: 222 citations2004: 163 citations2005: 199 citations2006: 219 citations2007: 217 citations2008: 230 citations2009: 273 citations2010: 273 citations2011: 331 citations2012: 326 citations2013: 289 citations2014: 294 citations2015: 324 citations2016: 314 citations2017: 254 citations2018: 201 citations2019: 997 citations2020: 1,162 citations2021: 967 citations2022: 720 citations2023: 475 citations2024: 1,058 citations2025: 298 citations2026: 2 citations1977–1990: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,811 citing papers, 28.4% of this breakdownGermany: 715 citing papers, 7.2% of this breakdownFrance: 583 citing papers, 5.9% of this breakdownItaly: 558 citing papers, 5.6% of this breakdownUnited Kingdom: 554 citing papers, 5.6% of this breakdownChina: 425 citing papers, 4.3% of this breakdownSpain: 389 citing papers, 3.9% of this breakdownNetherlands: 346 citing papers, 3.5% of this breakdownCanada: 334 citing papers, 3.4% of this breakdownJapan: 291 citing papers, 2.9% of this breakdownSwitzerland: 266 citing papers, 2.7% of this breakdownAustralia: 253 citing papers, 2.6% of this breakdown
0%28.4%Other 24%

Fields

  • Medicine89.2%
  • Immunology and Microbiology5.1%
  • Biochemistry, Genetics and Molecular Biology3.2%
  • Engineering0.7%
  • Psychology0.3%
  • Dentistry0.2%
  • Other1.3%

Topics

  • Hematopoietic Stem Cell Transplantation19.3%
  • Acute Myeloid Leukemia Research6%
  • Acute Lymphoblastic Leukemia research4.6%
  • Immune Cell Function and Interaction4.6%
  • T-cell and B-cell Immunology4.1%
  • Cytomegalovirus and herpesvirus research2.9%
  • Other58.5%

Coauthors

All papers

Open in search
  1. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2014 cited by 5,394

  2. HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2008 cited by 1,906

  3. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2005 cited by 3,530

  4. Ibrutinib for chronic graft-versus-host disease after failure of prior therapy

    Authors: , , , , , , , , , , , , , , , , - Blood 2017 cited by 499

  5. EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment

    Authors: , , , , , , , , , , , , , - Bone Marrow Transplantation 2018 cited by 491

  6. Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report

    Authors: , , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2015 cited by 419

  7. Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert Peter Gale, John Koreth, Nelson J. Chao, Mahmoud Aljurf, Brenda Cooper, Mary J. Laughlin, Jack W. Hsu, Peiman Hematti, Leo F. Verdonck, Melhelm M. Solh, Maxim Norkin, Vijay Reddy, Rodrigo Martino, Shahinaz M. Gadalla, Jenna D. Goldberg, Philip L. McCarthy, Josè Antonio Pérez-Simón, Nandita Khera, Ian D. Lewis, Yoshiko Atsuta, Richard F. Olsson, Wael Saber, Edmund K. Waller, Didier Blaise, Joseph A. Pidala, Paul J. Martin, Prakash Satwani, Martin Bornhäuser, Yoshihiro Inamoto, Daniel J. Weisdorf, Mary M. Horowitz, Steven Z. Pavletic - Biology of Blood and Marrow Transplantation 2014 cited by 435

  8. Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD Consortium

    Authors: , , , , , , , , , , , , - Blood Advances 2021 cited by 140

  9. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria

    Authors: , , , , , , , , , , , , , , , - Blood 2011 cited by 681

  10. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Transplantation and Cellular Therapy 2021 cited by 167

  11. How we treat chronic graft-versus-host disease

    Authors: , - Blood 2014 cited by 374

  12. Risk factors for acute GVHD and survival after hematopoietic cell transplantation

    Authors: , , , , , , , , , , , , , , , , , , , , , - Blood 2011 cited by 697

  13. Cord-Blood Transplantation in Patients with Minimal Residual Disease

    Authors: , , , , , , , , , , , , , , , - New England Journal of Medicine 2016 cited by 441

  14. Ibrutinib for Chronic Graft-versus-Host Disease After Failure of Prior Therapy: 1-Year Update of a Phase 1b/2 Study

    Authors: , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2019 cited by 112

  15. Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , M. Robinson, Michael E. Ward, Bryce B. Reeve, Lisa G. Rider, Howard M. Shulman, Kirk R. Schultz, Daniel Weisdorf, Georgia B. Vogelsang - Biology of Blood and Marrow Transplantation 2006 cited by 565

  16. Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation

    Authors: , , , , , , , , , - Blood 2016 cited by 228

  17. Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation

    Authors: , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2015 cited by 177

  18. Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AML

    Authors: , , , , , , , , , , , , , , - Blood 2022 cited by 81

  19. Chronic graft-versus-host disease

    Authors: , , - Biology of Blood and Marrow Transplantation 2003 cited by 954

  20. NIH Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. The 2014 Pathology Working Group Report

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2015 cited by 315

  21. Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK–modified donor T cells after allogeneic hematopoietic cell transplantation

    Authors: , , , - Blood 2005 cited by 338

  22. Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation

    Authors: , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2015 cited by 211

  23. Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 cited by 54

  24. Chronic graft-versus-host disease and other late complications of bone marrow transplantation.

    Authors: , , , , , , , , , - 1991 cited by 802